Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04540939 · ClinicalTrials.gov registry record · NA
Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for PTSD - COVID Related Substudy
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT04540939 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 59 participants.
The verdict
NCT04540939, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
This clinical trial is a sub-study to treat participants that were not eligible in the main study (HUM00152509/NCT03874793) to receive MBCT or MRT in hard hit COVID-19 areas with trauma history and current COVID-related distress. The purpose of this treatment-only sub-study is to see how eligible participants with life history of any trauma and are currently experiencing elevated COVID-related stress are affected by two different PTSD therapies involving Mind-Body practices; Mindfulness based Cognitive Therapy (MBCT) and Muscle Relaxation Therapy. The targeted individuals will reside in areas (Washtenaw, Wayne, and Oakland counties in Michigan, etc.) that have been affected by COVID-19. Participants will have assessments before and after 8 weeks of therapy (remote MBCT or MRT).
Interventions
- BEHAVIORAL Mindfulness-Based Cognitive Therapy
- BEHAVIORAL Muscle Relaxation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2020-10-19 |
| Est. Completion | 2023-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04540939
The ClinicalTrials.gov registry entry for NCT04540939 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mindfulness-Based Cognitive Therapy is the first listed.
NCT04540939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04540939 about?
NCT04540939 is a clinical study titled "Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for PTSD - COVID Related Substudy". This clinical trial is a sub-study to treat participants that were not eligible in the main study (HUM00152509/NCT03874793) to receive MBCT or MRT in hard hit COVID-19 areas with trauma history and current COVID-related distress. The purpose of this treatment-only sub-study is to see how eligible p...
What is the current status of trial NCT04540939?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2020-10-19. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT04540939?
The interventions under investigation include: Mindfulness-Based Cognitive Therapy (BEHAVIORAL), Muscle Relaxation Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04540939?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.